Publicacións en colaboración con investigadores/as de Hospital Universitario Son Espases (52)

2024

  1. Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia

2023

  1. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 7, pp. 1934-1948

  2. Exacerbations in COPD: a personalised approach to care

    The Lancet Respiratory Medicine

  3. Factors associated with suboptimal response to monoclonal antibodies in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology

  4. First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

    Journal of Investigational Allergology and Clinical Immunology

  5. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2732-2747

  6. Redefining the Role of Bronchoscopy in the Workup of Severe Uncontrolled Asthma in the Era of Biologics: A Prospective Study

    Chest, Vol. 164, Núm. 4, pp. 837-845

  7. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

  8. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

  9. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

  10. Transition of Adolescents With Severe Asthma From Pediatric to Adult Care in Spain: The STAR Consensus

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 179-189

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group

    Archivos de Bronconeumologia, Vol. 58, Núm. 11, pp. 776-779

  3. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  4. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 5, pp. 1202-1216.e23

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

    Journal of Asthma and Allergy, Vol. 15, pp. 63-78

  7. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Characterization of COPD admissions during the first COVID-19 outbreak

    International Journal of COPD, Vol. 16, pp. 1549-1554